...
机译:具有严重感染和次生抗体缺陷的固体器官移植静脉内免疫球蛋白替代疗法:概念证明
Univ Complutense Madrid Immunol Oftalmol &
ORL Dept Madrid Spain;
Hosp Gen Univ Gregorio Maranon Cardiol Dept Madrid Spain;
Hosp Gen Univ Gregorio Maranon Immunol Dept Transplant Immunol Grp Madrid Spain;
Hosp Gen Univ Gregorio Maranon Cardiol Dept Madrid Spain;
Hosp Gen Univ Gregorio Maranon Immunol Dept Transplant Immunol Grp Madrid Spain;
Hosp Gen Univ Gregorio Maranon Nephrol Madrid Spain;
Hosp Gen Univ Gregorio Maranon Nephrol Madrid Spain;
Hosp Gen Univ Gregorio Maranon Gastroenterol Madrid Spain;
Hosp Gen Univ Gregorio Maranon Gastroenterol Madrid Spain;
Hosp Gen Univ Gregorio Maranon Microbiol &
Infect Dis Dept Madrid Spain;
Hosp Gen Univ Gregorio Maranon Microbiol &
Infect Dis Dept Madrid Spain;
Hosp Gen Univ Gregorio Maranon Immunol Dept Transplant Immunol Grp Madrid Spain;
机译:具有严重感染和次生抗体缺陷的固体器官移植静脉内免疫球蛋白替代疗法:概念证明
机译:移植后抗体缺乏和严重感染的心脏接受者静脉注射免疫球蛋白替代治疗后体液免疫的恢复
机译:在静脉内免疫球蛋白治疗后,患有次生抗体缺乏和严重感染的心脏受与者死亡率较低
机译:新的预后实验室参数和静脉内激胶蛋白G重置严重H1N1感染的使用
机译:加拿大住院固体器官移植受者感染的临床和经济负担
机译:症状初级免疫球蛋白G(IgG)缺陷患者的健康状况和感染接受静脉注射IGG替代
机译:原发性抗体缺乏症患者从静脉或16%皮下替代疗法转变为20%皮下免疫球蛋白